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Abstract
Spread of antibiotic resistance among bacteria responsible for nosocomial and community-acquired infections urges for
novel therapeutic or prophylactic targets and for innovative pathogen-specific antibacterial compounds. Major challenges
are posed by opportunistic pathogens belonging to the low GC% Gram-positive bacteria. Among those, Enterococcus
faecalis is a leading cause of hospital-acquired infections associated with life-threatening issues and increased hospital costs.
To better understand the molecular properties of enterococci that may be required for virulence, and that may explain the
emergence of these bacteria in nosocomial infections, we performed the first large-scale functional analysis of E. faecalis
V583, the first vancomycin-resistant isolate from a human bloodstream infection. E. faecalis V583 is within the high-risk
clonal complex 2 group, which comprises mostly isolates derived from hospital infections worldwide. We conducted broad-
range screenings of candidate genes likely involved in host adaptation (e.g., colonization and/or virulence). For this purpose,
a library was constructed of targeted insertion mutations in 177 genes encoding putative surface or stress-response factors.
Individual mutants were subsequently tested for their i) resistance to oxidative stress, ii) antibiotic resistance, iii) resistance
to opsonophagocytosis, iv) adherence to the human colon carcinoma Caco-2 epithelial cells and v) virulence in a surrogate
insect model. Our results identified a number of factors that are involved in the interaction between enterococci and their
host environments. Their predicted functions highlight the importance of cell envelope glycopolymers in E. faecalis host
adaptation. This study provides a valuable genetic database for understanding the steps leading E. faecalis to opportunistic
virulence.
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Introduction
Enterococci are ubiquitous low-GC percent Gram-positive
bacteria. The two clinically predominant species E. faecalis and
E. faecium are natural members of the digestive microbiota in
humans. Interestingly, they are also found as members of the
natural microflora of a variety of fermented food products [1,2].
While not regarded as particularly virulent, both species have
emerged as major causes of nosocomial infections. They are the
second most common cause of nosocomial bloodstream infections
in the United States [3] and the fourth in Europe (http://www.
earss.rivm.nl/). Enterococci cause disease mainly in patients i)
undergoing prolonged antibiotic treatments, ii) with severe
underlying diseases, and iii) with an impaired immune system
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therapy) [4]. They are mainly responsible for urinary tract
infections, bacteremia, wound infections, and endocarditis [5],
with E. faecalis accounting for 60 to 80% of all enterococcal
infections [5,6].
Enterococci are intrinsically resistant to a broad range of the
antibiotics commonly used in the hospital setting, which in part
explains their high prevalence in nosocomial infections [7]. Their
acquired resistance to most antibiotics used in the hospital,
including acquired vancomycin resistance, is most worrisome since
it limits therapeutic alternatives against multiply resistant strains.
Furthermore, enterococci are considered a reservoir for antibiotic
resistance genes, as may be exemplified by their ability to transfer
vancomycin resistance to methicillin resistant Staphylococcus aureus,
for which vancomycin remains the last therapeutic alternative [8],
and to other bacterial genera [9].
As part of the normal intestinal microbiota, E. faecalis can cross
the intestinal epithelial barrier and enter the bloodstream
[10,11,12,13]. Macrophages have been suggested to serve as
vehicles for enterococcal invasion and dissemination [10]. To
survive within macrophages, bacteria must adapt to this
intracellular environment. They have to cope with the host cell
stress arsenal of antimicrobial defenses, including the production
of reactive oxygen species and the low pH of the phagosome [14].
The enterococcal adaptation and virulence factors remain only
partially understood.
Over the last fifteen years, a number of studies have attempted
to identify E. faecalis virulence factors (for review [15,16,17]). The
putative E. faecalis virulence genes include the surface adhesins
Esp, AS and Ace, the secreted toxin cytolysin Cyl, the secreted
proteases GelE and SrpE, two cell wall polysaccharides, Cps and
Epa, and the internalin-like protein ElrA. Transcriptional
regulators found to be involved in E. faecalis virulence are the
Agr-like Fsr system [18], EtaRS [19] and HypR [20,21]. In
addition, analyses of the E. faecalis V583 genome and pathogenic-
ity island of E. faecalis strain MMH594, two strains of the high-risk
enterococcal clonal complex 2 (CC2) responsible for infections in
hospitalized patients, led to the identification of a number of genes
that may also encode putative E. faecalis virulence factors [22,23].
These entail putative adhesins and invasins, exoenzymes, prote-
ases, and surface and extracellular proteins. However, these
predictions need to be validated by functional studies, which may
have been limited by difficulties in genetic manipulation of the
encapsulated V583 strain, which is resistant to multiple antibiotics
and carries three replicating plasmids [24,25].
The aim of our study was to identify new E. faecalis host
adaptation factors allowing this bacterium to be an opportunistic
pathogen in humans. Therefore, we used the published V583
genome sequence to compile a list of genes with potential
involvement in virulence. We then designed a mutational system
that was used in a systematic post-genomic approach for
inactivation of 177 of the selected genes of E. faecalis. The mutants
were subjected to a series of assays that examined their ability to
resist several life-style-related conditions. These combined efforts
led to the identification of numerous genes playing a role under
these conditions.
Results
Target gene selection, selection of a plasmid-free
derivative of E. faecalis V583 and production of a library
of targeted mutants
Analysis of the E. faecalis V583 genome led to the selection of
223 putative virulence gene candidates encoding i) surface exposed
proteins such as cell wall-anchored proteins, lipoproteins and
transporters and proteins involved in surface polysaccharides or
lipopolysaccharides synthesis; ii) putative transcriptional regula-
tors; iii) proteins of unknown function identified as specific to E.
faecalis; iv) enzymes involved in carbohydrate metabolism; v)
proteins involved in stress resistance; or vi) proteins similar to
known virulence factors, such as hyaluronidase, internalin-like
protein, and proteases. A percentage of 85 and 15 of the selected
genes are part of the core genome or located on mobile genetic
elements, respectively, including 17 genes that are present in the
pathogenicity island [23].
To avoid problems related to the presence of replicating
plasmids we selected a plasmid-cured derivative of strain V583, as
described in the Materials and Methods section, named VE14089.
This strain has not undergone major DNA rearrangements, as
indicated by DNA microarray analysis, pulsed field gel electro-
phoresis, Southern blotting, long-range PCR and DNA sequenc-
ing analyses, with one exception: a 20.5-kb region of pTEF1 (from
efa0063 up to efa0006) is integrated between chromosomal genes
ef3209 and ef3210, and is flanked by two copies of IS1216.A s
expected, the cured strain was sensitive to erythromycin and
gentamicin and related macrolides and aminoglycosides resulting
from plasmid loss, but remains as resistant as the wild-type strain
V583 to other antibiotics tested. We compared both strains for
several phenotypes. The cured strain demonstrated a growth
defect in comparison to the parental strain which was more
pronounced under aerobic than anaerobic conditions. However,
the cured strain had an only minor reduced ability to cause
lethality in the Galleria mellonella virulence model (Fig. S1),
indicating that strain VE14089 remained relevant for E. faecalis
genetic studies on virulence.
The system for generating targeted chromosomal insertions by
homologous recombination is based on the conditional replication
of two plasmids [26]. Plasmid pVE14218 (RepA2) is a cloning
vector with a tetracycline marker used to clone internal fragments
of each gene to be inactivated. Plasmid pG+host3 is a thermo-
sensitive helper plasmid that provides the RepA replication protein
to pVE14218 at permissive temperature. The pVE14218
derivative plasmids were integrated in the targeted loci as
described in Material and Methods. Thus, from a total of 223
gene disruptions attempted on candidates, 177 isogenic V583-
derived mutants were successfully obtained, which targeted genes
in 14 of the 20 gene role categories as defined by the JCVI CMR
database (Table S1). Unsuccessful mutagenesis could be explained
either by an essential role of the targeted genes in the conditions
used and/or their poor recombinogenic potential. One-third of the
mutants target functions involved in cell envelope and in transport.
The whole mutant library was then submitted to several test
conditions. The target genes were assigned as affecting four
categories of phenotypes related to host adaptation, namely: (i)
stress and antibiotic resistance, (ii) resistance to opsonophagocy-
tosis, (iii) adherence to Caco-2 epithelial cells and (iv) virulence in a
Galleria mellonella insect model.
Mutant growth behavior, fitness in stressing
environment and resistance to antibiotics
Growth behaviour and fitness under oxidative stress conditions
have been tested for the entire E. faecalis mutant library using
microtiter plate assays. The analyses evidenced more or less
important growth defects under non-stress condition in 10 of the
mutants (Table S1). The strongest effects were observed in strains
with mutations in genes encoding putative glycosyltransferases
(EF2167, EF2170 and EF2196). The majority of the strains (125)
showed no significant differences in sensitivity to exposure to
Host Adaptation Factors of Enterococcus faecalis
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more sensitive to H2O2 were grouped in three categories with
respect to the degree of their sensitivities (slightly, highly and
extremely sensitive) to the stressing agent (Table S2). The most
sensitive mutants were affected in genes encoding transcriptional
regulators (EF0073 and EF1599) belonging to the Cro/CI family,
EF0107 present in the Arginine deiminase operon [27] and
EF1525, one of the three Fur-paralogs, proteins implicated in
envelope metabolism (EF1172, EF1746, EF2170, EF2180,
EF2196, EF2198), a paralog of the virulence factor Gls24
(EF0604 encoded by the PAI), an ABC transporter (EF1408)
and the antioxidant activity and virulence factor MsrB (EF3164)
[28]. Of note, no mutant more resistant to H2O2 than the parental
strain was identified.
Antibiotic resistance of the VE14089 strain and all its isogenic
mutants was determined for 34 antibiotics that, together, cover all
known mechanisms of antibiotic action (Table S3). More than
88% of the mutants showed no modification of their antibiotic
resistance, including 7 mutants in genes annotated as having a role
in drug resistance (ef0420, ef0785, ef1042, ef1814, ef1943, ef2068
and ef2772; see Table S3). Of the 21 mutants displaying a modified
antibiotic resistance profile, increased sensitivity to ceftriaxone was
observed in a mutant with an interrupted npr-gene (ef1211). This
gene encodes the well characterized NADH peroxidase of E.
faecalis and its main cellular role is to protect cells against internal
metabolically-derived oxidative stress [29]. Two mutants puta-
tively affected in the cell envelope were more sensitive to fusidic
acid (ef1746 and ef2181); this might relate to changes in cell
permeability. Five mutants showed increased resistance to
amoxicillin and 2 to chloramphenicol; the targeted genes are
predicted to have roles in signal transduction (n=3), in cell
envelope (n=2), in cellular processes (n=1) and in protein fate
(n=1). Among the low number of mutants that showed altered
antibiotic sensitivity, we noted a significant enrichment of genes
affected in the categories ‘‘cell envelope’’ and ‘‘signal transduc-
tion’’ compared to the representation of these two categories in the
entire mutant collection (Table 1).
Resistance to opsonophagocytosis
Opsonic killing of bacteria constitutes a reliable in vitro surrogate
of protective immunity in vivo and occurs in the presence of specific
antibodies, complement, and phagocytes [30]. Different structures
on the bacterial surface can be the target of opsonic antibodies and
the loss of such structures will render the mutant more resistant to
opsonic killing. Specific mechanisms of the bacteria to withstand
the protective immune response of the host can be observed in the
same assay by identifying mutants that become hyper-susceptible
to opsonic killing when one of these factors is eliminated [31].
Sera raised against E. faecalis V583 were tested for their opsonic
killing activity against the various mutant strains. From 177
mutants tested, only 3 were more resistant to opsonophagocytosis
while 11 were more sensitive (1 with complement alone and 10
without antiserum, see Table S4). Among these, 10 (9 sensitive and
1 resistant mutant) carried mutations in genes predicted to have a
role in the cell envelope. In contrast to the VE14089 strain, most
of these mutants were efficiently killed by a combination of
polymorphonuclear neutrophils (PMNs) with complement, while
the additional effect of antibody opsonization was negligible. Two
mutants targeted in genes probably involved in wall-teichoic acid
synthesis (ef1172, ef1173) were susceptible to complement and
PMNs. Three mutants displayed significantly higher resistance to
opsonic killing compared to the wild-type. Two were mutated in
adjacent transcriptional regulator genes ef0600–ef0601, which are
part of the pathogenicity island of strain V583 enriched in CC2
complex [32] and both encode regulators of the TetR family of
transcriptional regulators. One strain mutated in gene ef2490 (cpsF)
was also more resistant to opsonic killing. CpsF is responsible for
the sero-specificity of serotype C to which VE14089 as a derivative
Table 1. Percentage of mutants in each JCVI role category.
JCVI role category
% mutant collection
n=177 % mutant affected in the following phenotype
Sensitivity
to H2O2
Sensitivity to
antibiotics
Opsonophago-
cytosis assay
Virulence in G.
mellonella
n=52 n=21 n=14 n=57
Biosynthesis of cofactors,
prosthetic groups, and carriers
0.6 1.9 - - -
Cell envelope 24.3 25.0 38.1* 71.4* 26.3
Cellular processes 7.9 7.7 9.5 - 3.5
Energy metabolism 6.8 5.8 14.3 - 5.3
Fatty acid and phospholipid metabolism 4.5 - - - 1.8
Hypothetical proteins 9 9.6 - 7.1 7
No Data 5.6 9.6 4.8 - 7
Protein fate 4.5 1.9 4.8 - 5.3
Protein synthesis 1.1 1.9 - - -
Regulatory functions 14.1 15.4 4.8 14.3 21.1
a
Signal transduction 2.8 - 14.3* - 3.5
Transcription 0.6 - - - -
Transport and binding proteins 15.3 17.3 9.5 7.1 19.3
Unknown function 2.8 3.8 - - -
aSignificant enrichment compared to the frequency in the mutant collection.
doi:10.1371/journal.pone.0029023.t001
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CpsF changes this strain to sero-group D thereby abrogating the
activity of anti-serotype C antibodies [34]. Disruption of capsule
genes ef2491 (cpsE) and ef2492 (cpsD) did not increase susceptibility
to killing by complement and PMNs. This result may be explained
by the fact that LTA unmasked by capsular polysaccharide also
protects E. faecalis from opsonic killing [33,34,35].
Adhesion to Caco-2 epithelial cells
Non-invasive bacteria that colonize the gastrointestinal tract,
such as entero-hemorrhagic Escherichia coli (EHEC), adhere tightly
to epithelial cells and promote pedestal formation [36]. Although
there is no consensus about the capacity of enterococci to invade
epithelial cells, adherence to such cells is likely to contribute to
enterococcal pathogenesis. To evaluate this ability in the 177 E.
faecalis mutants, we used a 96-well microtiterplate screening model
for adherence of E. faecalis to cells of the human colon carcinoma
Caco-2 epithelial cell-line. This cell-line has already proven to be a
valuable model for testing adherence of E. faecalis to epithelial cells
[37,38].
Eighty-four percent of the mutants were not modified with
respect to their adhesion to the intestinal epithelial cells. Four
mutants displayed a decreased ability to adhere (Table S5); the
interrupted genes have predicted roles in signal transduction (PTS
system; ef0553), in cell envelope (ef0252) and in cellular processes
(ef1076). In one of the adhesion-defective mutants, a hypothetical
protein (EF0876) was affected that carries a domain found in the
streptococcal regulator Mga, which is known to regulate
production of adhesins in group A streptococci [39]. Interestingly,
24 mutants showed increased adhesion to the epithelial cells, 9 of
which carried mutations in genes with a predicted role in the cell
envelope, such as polysaccharide biosynthesis or degradation.
Virulence in the Galleria mellonella insect model
Increasing interest in using G. mellonella as a surrogate model to
study virulence of various microorganisms led us to compare the
virulence of the 177 mutant strains with that of the parental strain.
One third of the mutants (n=57) were modified in virulence in this
model: 49 showed decreased virulence and 8 were more virulent
(Fig. S2, Table S6). Most of the mutations of both mutant categories
are in genes potentially involved in cell envelope metabolism,
regulatory functions and transport. Eight genes encode proteins of
unknown function, including 3 of which the products are predicted
to locate at the cell envelope (ef1420, ef2250 and ef2276). A slight
enrichment in the category ‘‘Regulatory Function’’ is observed
(Table 1). The diversity of the regulator classes affecting E. faecalis
virulence indicates that this process relies on a large number of
functions in this model. Bacterial virulence in insects such as the
Lepidoptera G.mellonellalies inthe ability to resistthe innate immune
response, which includes the action of lysozyme, antimicrobial
peptides and reactive oxygen and nitrogen species such as hydrogen
peroxideand nitricoxide [40]. Among the attenuated mutants,some
carry mutations in genes well known to participate in resistance to
antimicrobial peptides of E. faecalis or other bacteria. These include
genes involved in the dealanylation of LTA (ef2746 and ef2748), in
the biosynthesis of teichoic acids (ef1172 and ef1175), in membrane
phospholipid synthesis (ef1027,a nmprF-like gene) or potential efflux
pumps (ef0785, ef1760, ef1814 and ef2068).
Combined phenotypic analysis of the E. faecalis mutant
library
All the data collected for each of the mutants constructed in this
study were entered in an easy-access phenotypic database (http://
genome.jouy.inra.fr/phenotype/). From the 177 mutant strains,
more than 1/3 showed no detectable phenotype and 36% (n=64),
19% (n=34) and 6% (n=11) were tested positive for one, two and
more than two phenotypes, respectively. A Venn diagram was
constructed according to the intersection of predicted genes in the
5 phenotyping tests, with the exception of the increased adhesion
phenotype (Fig. 1). In this analysis, a handful of phenotype
combinations were observed, the most frequent being the
combination of resistant to H2O2 and virulent in G. mellonella.
Noticeably, the majority (13/14) of the mutants affected in the
opsonophagocytosis assay displayed at least another phenotype,
with sensitivity to H2O2 and virulent in G. mellonella being the most
prevalent. Furthermore, half of the mutants with modified
antibiotic resistance are affected in virulence. One mutant
exhibited four phenotypes (ef1746) while 8 mutants displayed
three phenotypes (ef1027, ef1172, ef1705, ef2170, ef2196, ef2198,
ef2167, ef2992). The affected genes mostly encode proteins with
predicted roles in cell envelope metabolism, in polysaccharide
synthesis or degradation, or in transport or substrate binding.
Discussion
Bacterial pathogens that invade the animal host are faced with
various hostile conditions aimed at their elimination, via products
of the host innate and adaptive immune responses, and in some
cases, antibiotics. Success of the pathogen requires its evolving
capacity to withstand host defenses. Various global approaches
have been applied to search for bacterial genes that increase
pathogenicity, which include screening of random mutant libraries
in animal models and in vitro tests mimicking a specific stage of the
infection (e.g. challenges with H2O2, acid or antimicrobial
peptides, growth in a biofilm), and in vivo mRNA transcriptome
analyses [41,42]. So far, large-scale screening for host adaptation
factors has rarely been applied to E. faecalis, and strain V583,
which belongs to clonal complex 2, has been thus far overlooked
[43,44,45,46]. To deepen our knowledge of factors involved in
enterococcal virulence, we constructed a bank of 177 targeted
mutants in V583 genes that were chosen on the basis of their
potential roles in host fitness. This first large set of isogenic E.
faecalis V583 mutants constitutes a unique resource for identifying
genes, and functions that are important under various E. faecalis
life-style related conditions (e. g. biofilm formation, exposure to
biocides, and interaction with host cells). This work should thus
help elucidate the mechanisms involved in E. faecalis infection.
Our approach consisted of individual screening of all mutants
for phenotypes related to the enterococcal in vivo lifestyle: antibiotic
resistance, oxidative stress resistance, adherence, and infection.
Almost two thirds of the mutants (n=109) exhibited a phenotype
under the conditions tested, thus supporting the relevance of our
initial choice of target genes. Our next step is to confirm the
association between phenotype and the target mutations, so as us
to rule out possible polar effects or secondary mutations among the
mutated strains. Importantly, the majority of these mutants (n=91
out of 109) were affected in oxidative stress responses and/or in
virulence. A minority (n=32 out of 109) displayed modified
resistance to opsonophagocytosis or to antibiotics, but most of
these were multiply affected. A total of 45 mutants displayed
multiple phenotypes. The observed phenotypes correlate with the
importance for the successful bacterial pathogen to overcome
phagocytosis and the cognate oxidative burst, as well as cell wall
stress caused by the action of lysozymes and antimicrobial peptides
[47,48]. The significant overlap between antibiotic resistance and
virulence phenotypes suggests that factors for intrinsic antibiotic
resistance are probably involved in general stress response and
Host Adaptation Factors of Enterococcus faecalis
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phenotypes associated with mutations in surface functions
underline the role of the cell envelope in combating external
stress conditions encountered in the host. As discussed below,
glycopolymers, rather than proteins, emerged from this study as
the main structural group responsible for E. faecalis defense against
multiple external assaults (Fig. 2).
Our and previous work point to a major role of cell wall
glycopolymers including polysaccharides in protection against the
host responses and in bacterial colonization of mucosal surfaces in
both commensals and pathogens [49]. The most abundant
enterococcal glycopolymers are lipid-attached lipoteichoic acids
(LTA), peptidoglycan-attached wall teichoic acids (WTA) [50] and
glycolipids [31,38]. The best studied enterococcal cell wall
polysaccharides are a rhamnopolysaccharide (Epa; this polysac-
charide is the presumed product of the epa locus) and a type-
specific capsular polysaccharide (Cps) [51,52,53,54]. Results of our
mutants affecting different glycopolymers are presented according
to the class of glycopolymers that are affected.
GalU (EF1746; uridine diphosphoglucose pyrophosphorylase)
converts glucose-1 phosphate to UDP-glucose, an essential
substrate for LTA glycolipid anchor synthesis and a precursor
for the synthesis of sugar polymers such as exocellular (lipo)poly-
saccharides [55]. Inactivation of galU gave a pleiotropic effect, with
4 detected phenotypes. GalU was previously implicated in
Streptococcus pneumoniae capsular polysaccharide biosynthesis and
virulence [56]. The present results on the role of galU in E. faecalis
suggest that this enzyme may be of general importance among the
opportunist pathogens for host adaptation.
WTA and LTA are implicated in attachment to epithelial and
endothelial surfaces and to biomaterials, and in host cell invasion,
as reported in numerous Gram-positive bacteria [57]. In our work,
inactivation of TagB (EF1172), a glycerophosphotransferase
required for WTA biosynthesis, resulted in a strain with multiple
phenotypes. In view of this predicted function of tagB, the absence
of WTA in the tagB mutant should lead to an increased negative
bacterial net charge. A consequence of surface charge modifica-
tions is an altered susceptibility to cationic antimicrobial peptides
[50,58]. Such consequences are in keeping with the observed tagB
multiple phenotypes in E. faecalis. Interestingly, inactivation of
ef1027, encoding a putative MprF-like protein also led to multiple
phenotypes. MprF is a membrane protein catalyzing the
modification of the negatively charged lipid phosphatidylglycerol
with L-lysine or L-alanine, thus neutralizing the membrane surface
[59]. These modifications could explain previous observations of
attenuated reduced virulence in the mprF mutant in S. aureus,
Listeria monocytogenes and Mycobacterium tuberculosis [60,61,62]. As
with the tagB mutant, loss of mprF might result in an increased
negative membrane charge, and might consequently contribute to
cationic antimicrobial peptides sensitivity and more generally to
host fitness.
The epa operon required for rhamnopolysaccharide biosynthesis
involves V583 genes ef2198 to ef2177, as extrapolated from
assignments in E. faecalis strain OG1RF (in which epa comprises 18
genes, epaA to epaR [51,54,63]. E. faecalis V583 mutants that
mapped in the epa region (ef2196 and ef2198) or adjacently (ef2167
and ef2170) all displayed multiple phenotypes In OG1RF, mutants
in epaB (ef2197) and epaE (ef2194) were attenuated for virulence in a
Figure 1. Venn diagram representation of the results of the five phenotypic tests performed on the mutants obtained in this study.
Only genes that are common to at least two phenotypes are listed. The increased adhesion phenotype was not included due to difficulties in
constructing the Venn diagram with these data. Stars indicate mutants with increased adhesion phenotype.
1 The 10 mutants combining phenotypes
for H2O2 stress and virulence are not shown due to lack of space in the figure. They were inactivated in ef0073, ef0465, ef0814, ef1212, ef1420, ef1493,
ef1741, ef1760, ef1798 or ef2442.
doi:10.1371/journal.pone.0029023.g001
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[53], and were deficient in translocation across enterocyte-like T84
cells [65] and biofilm formation [54,66]. The pleiotropic effects of
ef2196 and ef2198, all tested in parallel, give support for a key role
of epa in host adaptation. The fact that the strongest in vitro growth
defect was observed when mutations occurred in this locus
supports the idea that the epa genes have a general role in the
physiology of the bacteria and represent fitness rather than bona fide
virulence factors. The absence of potential transcriptional
terminators separating genes ef2167 and ef2170 from epa, coupled
with the identical phenotypes obtained for the four mutants, leads
us to suggest that the epa locus in V583 spans genes ef2198 to
ef2164. Genes ef2167 and ef2170 are enriched in isolates of the
high-risk enterococcal clonal complex 2 [32,67,68], and we predict
their products are involved in structural diversity of Epa.
Our studies point to the general importance of glycopolymers
for defense against commonly encountered stress conditions. Based
on the successful development of vaccine strategies using
glycopolymers of several pathogens [58], and on promising results
with enterococcal LTA [69,70], it is tempting to propose E. faecalis
glycopolymers as vaccination targets.
Mutants inactivated for inorganic ion transport systems or their
corresponding regulatory functions also displayed pleiotropic
phenotypes. As described in other bacterial species, phosphate
uptake systems may additionally transport metals [71,72,73]. Since
metals can increase oxidative stress [74], sensitivity of two mutants
in ef1705 and ef2442 to oxidative stress could result from disrupted
metal homeostasis. Maintenance of metal homeostasis appears to
be important for resistance to harsh conditions found in the host.
Fur-like regulators control intracellular concentrations of iron, zinc
or other metals in many bacteria, and may impact on host fitness
[75]. E. faecalis strains inactivated for these regulators (EF1525,
EF1585 and EF2417) gave results similar to those with the ion
transport mutants, suggesting that these mutations may affect
common functions. Of the 3 Fur family transcriptional regulators
tested, only PerR (EF1585) has been studied in E. faecalis JH2-2
[76]. Inactivation in strain V583 of EF1585 (PerR) or EF2417
attenuated virulence in the G. mellonella insect model, and deletion
of EF1525 increased both sensitivity to H2O2 and resistance to
gentamycin. These results suggest that E. faecalis paralogs of Fur-
like proteins somehow have a dedicated role in host fitness. As the
paralogs could compensate each other, at least partially from
overlapping phenotypes, they could contribute to the flexibility of
the cell to adapt to different environmental conditions.
In conclusion, this study provides the first large collection of
isogenic mutants of CC2 isolate V583 available to the scientific
community, and the first large-scale functional characterization
regarding multiple phenotypes related to E. faecalis host adapta-
tion. Our study has highlighted the major and pleiotropic role of
E. faecalis cell wall glycopolymers under conditions that mimic host
adaptation, such as adhesion, resistance to immune response,
colonisation, and signalling. Further work will allow us to
characterize selected cell envelope-related fitness factors and to
identify how they mediate interactions with the host. Functions
identified in this work could be potential targets for preventive and
therapeutic anti-enterococcal regimens.
Materials and Methods
Bacterial strains, plasmids and culture conditions
Enterococcus faecalis V583 is a vancomycin resistant strain [25]
harboring three plasmids. Nucleotide sequences of the chromo-
some and plasmids are available at http://www.tigr.org. For
technical reasons we conducted the study with a plasmid cured
strain. Plasmid curing was carried out by a procedure combining
three conditions known to lead to plasmid loss: the use of
novobiocin [77] and growth at 42uC in a medium lacking its
buffering component [78]. Strain V583 was cultured for 96 hours
under these conditions and the procedure was repeated several
times. The successive strains obtained were: V583 EryS (carrying
pTEF2, and pTEF1 free of the EryR cassette), V32 (containing
pTEF1 free of the EryR cassette), and V19, renamed in this study
VE14089 (free of replicating plasmids). A transcriptional micro-
array was performed on strain VE14089 using the Affymetrix
GeneChip, SLARE1 [79], the details of transcriptome experi-
ments and analysis are described as additional information in Text
Figure 2. Schematic representation of E. faecalis V583 cell envelope, showing functions involved in pleiotropic stress protection. The
E. faecalis V583 cell envelope includes the peptidoglycan-anchored teichoic acid (WTA; burgundy), the membrane-anchored lipoteichoic acid (LTA;
green), the rhamnopolysaccharide (EPA; blue), and a capsular polysaccharide (CPS; purple). Names of genes predicted to participate in glycopolymer
synthesis are indicated with the cognate colour code. Membrane protein MprF-like is depicted in light orange.
doi:10.1371/journal.pone.0029023.g002
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public database at http://www.ebi.ac.uk/ arrayexpress with the
series accession number E-MEXP-3068. The microarray analysis
revealed that genes efA0063 to efA0006 from plasmid pTEF1 were
still present in this strain but PCR analysis at the borders of this
region demonstrated that a circular form of the plasmid was not
present. To identify the site of chromosomal integration, pulsed-
field gel electrophoresis of NotI, SfiI,o rSmaI digested VE14089
genomic DNA and subsequent Southern hybridization was
performed as described previously [80]. An intragenic probe for
efA0078 was amplified using the primers, efA78F 59-GGACTT-
GATCCATTGAAGAC-39, and efA78R 59-GGTAAAACCT-
GACTATTGCC-39, and radiolabeled by incorporation of
[a-
32P]dCTP-labelled deoxynucleotides (Perkin Elmer) using
Ready-To-Go DNA labelling beads (GE). Southern blot analysis
revealed a chromosomally integrated plasmid-fragment on two
possible SmaI restriction fragments of 105 kb or 110 kb. To
determine the site of integration, long-range PCRs were
performed in the 110-kb region, which allowed delimiting the
insertion within an intergenic region between the genes ef3209 and
ef3210. Finally, the precise integration site of the genes efA0063 to
efA0006 was determined by sequencing.
E. coli was cultivated at 37uC in LB broth (Difco) in a glass tube
with shaking. E. faecalis strains were grown in M17 broth (Difco)
supplemented with 0.5% glucose (GM17), or on GM17 agar plates
at an appropriate temperature. E. coli VE14188 (dam
2dcm
2
RepA
+) was used to amplify plasmids to be introduced in E.
faecalis. To maintain the conditionally replicating plasmid
pVE14218 and derivative plasmids, tetracycline was used at
12.5 mg/mL for E. coli and at 10 mg/mL for E. faecalis.T o
maintain plasmid pGhost3 (RepA
Ts), chloramphenicol was used at
10 mg/mL.
Transformation of E. coli and of E. faecalis
E. coli VE14188 and E. faecalis were transformed by electropo-
ration using a BioRad Gene Pulser apparatus according to the
method of Dower et al. [81] and Holo and Nes [82], respectively.
Briefly, 40 mL of electrocompetent cells of E. faecalis VE14412
were mixed with 2 mL of plasmid DNA (100 ng). After electric
shock, 1 mL of SM17MC medium (GM17 with 0,5 M saccharose,
10 mM MgCl2 and 10 mM CaCl2, pH 6,8–7,0) were added and
the cell suspension was incubated at 28uC for 2 h without shaking.
One hundred mLo f1 0
0 and 10
21 dilutions were spread on GM17
agar plates with 10 mg/mL tetracycline and incubated at 28uC for
48 h.
Extraction of plasmid DNA from E. coli and of total DNA
from E. faecalis
DNA of pVE14218 was purified using cesium chloride gradient
centrifugation [83] and cognate derivatives plasmids were purified
according to the protocol of the QIAprep Spin Miniprep Kit
(QIAGEN).
Total DNA from E. faecalis was extracted using a modified
protocol described by Brinster et al., 2007 [84]. Bacterial cells
were pelleted by centrifugation at 4uC, 8,000 rpm for 3 min. The
cell pellet was washed once in 1 ml of TES (50 mM Tris, pH 7.5;
20% sucrose, 5 mM EDTA), resuspended in 300 mL of TES+ly-
sozyme (5 mg/mL) and incubated for 30 min at 37uC. Protoplasts
were mixed with 300 mL of saline solution (150 mM NaCl;
10 mM EDTA, pH 8) and lysed by the addition of 20 mL of 20%
SDS. One volume of phenol/chloroform/isoamyl alcohol 25:24:1
(PCI) was added and the suspension was homogenised. DNA was
separated from cellular debris by centrifugation for 10 min at
14,000 rpm at 10uC. The PCI step was repeated once or twice on
the aqueous phase containing soluble DNA. Subsequently, the
DNA was precipitated by addition of one volume of isopropanol.
After centrifugation at 14,000 rpm, 10uC for 10 min, the
supernatant was discarded, the DNA pellet was washed in cold
70% ethanol, centrifuged for 5 min and then air-dried. DNA was
finally resuspended in 50 mLo fT E +RNAse (100 mg/mL),
incubated at least 30 min at 37uC. and stored at 220uC.
Generation of integrants of E. faecalis by thermal shock
Single colonies of E. faecalis containing both pGhost3, which
provides functional RepA
Ts, and the conditionally replicating
pVE14218-derivative were cultivated in 50 ml of GM17 (without
antibiotic) under static conditions for 2 h at 28uC. Then, the
cultures were transferred to the non-permissive temperature for
pGhost3 (42uC) for two hours to inhibit plasmid replication. Next,
serial dilutions were plated on GM17 containing 10 mg/ml
tetracycline (to select for plasmid integrants) and on GM17 (to
evaluate the integration rate) and incubated for 24 h at 42uC.
Thus, chromosomal integration of the specific pVE14218
derivative and loss of pGhost3 was selected for. Integration at
the targeted locus was validated by Southern Blot analysis using
the DIG DNA labeling and Detection kit (Roche) and/or PCR.
H2O2 stress resistance assay
Two ml of an overnight culture of E. faecalis was harvested, and
cells were suspended in 10 ml of GM17 medium. A volume of
180 ml of the resuspended culture was added to each well of a
microtiter plate to which 20 ml of 0 mM, 5 mM, 6 mM or 7 mM
H2O2 was added (thus giving 1/10
th final concentration; plates
were incubated for 2 h at 37uC without agitation. Twenty mlo f
culture from each well was then used to inoculate another
microtiter plate containing in each well 180 ml of GM17. Plates
were incubated at 37uC in a plate reader (BioRad Model 680), and
growth was monitored for 24 h by for OD600 every 30 min after
plate agitation for 10 s.
Antibiotic resistance assay
Resistance to 34 antibiotics, covering different classes. Both
intrinsic and acquired resistances were assessed, at first using disk
susceptibility tests. Screens were done according to the recom-
mendations of the disk providers. Subsequently, the minimal
inhibitory concentration (MIC) was determined for each antibiotic
using either the microdilution, agar dilution or E-test method and
results were interpreted according to the recommendations of the
Clinical and Laboratory Standards Institute (CLSI, formerly
NCCLS). The MICs were determined for mutants showing
relevant antibiotics phenotypes by the disk diffusion assays. MIC
values of mutant that were at least 2-fold different from that of the
parent strain VE14089 were considered significant.
Resistance to opsonophagocytosis
Rabbit sera raised against whole bacterial cells and known to
contain opsonic antibodies against E. faecalis V583 were tested for
their opsonic killing activity against E. faecalis reference strains as
described previously [31]. Polymorphonuclear neutrophils (PMN)
were freshly prepared from human blood collected from healthy
adult volunteers and percent killing was calculated by comparing
the colony counts in the inoculum (i.e., viable counts at time 0 –
T0) to the colony counts after a 90-minute incubation at 37uC
(T90), using the following formula: ((mean cfu at T0 – mean cfu at
T90)/(mean cfu at T0))6100. The killing activity of sera in
combination with complement and PMN was compared to control
samples with human sera and complement but without PMN.
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PMNs, complement, and antibodies, we observed the following
differences in some of the mutants: Killing by complement alone
(Complement Sensitivity: Co-Sens), Killing by complement and
PMNs but without antiserum (Serum Independent: Ser-Ind), and a
general higher resistance to killing with all three components
(Higher Resistance, High-Res).
Adhesion of E. faecalis to Caco-2 cells
The Caco-2 cell line from human colon adenocarcinoma was
obtained from the cell bank of the Centro de Investigaciones
Biologicas (CIB-CSIC, Madrid, Spain). Caco-2 cells were cultured
at 37uC under 5% CO2 in 24-well plastic microplates (TTP) in
RPMI medium 1640 (Invitrogen) containing 10% Foetal Bovine
Serum (Invitrogen), without antibiotics, until the cells were grown
to 695% confluence. The cell monolayers were washed with
sterile Phosphate Buffered Saline without Ca
2+ and Mg
2+
(Biowhitaker). The RPMI medium was removed, and fresh RPMI
medium was added before infection. The bacterial inoculum
consisted of a suspension in RPMI without Foetal Bovine Serum of
bacteria obtained from 1 ml (,10
9 bacteria) of an overnight
culture in 5 ml BHI at 37uC, centrifuged during 5 min at
6000 rpm. Briefly, bacterial suspensions were added to 695%
confluent Caco-2 monolayers at a multiplicity of infection (MOI)
of 50:1. Infected cell monolayers were centrifuged for 5 min at
500 rpm at room temperature and incubated for 2 h at 37uC
under 5% CO2. They were then washed 3 times with PBS. A 300-
ml volume of triton X-100 (Sigma) in 1% PBS was added per well.
Homogenates were collected and serial dilutions were plated on
BHI containing 10 mg/ml tetracycline for mutants and on BHI for
controls (strains V583 and VE14089) and incubated for 24 h at
37uC. Colonies were counted to assess adherent/invasive colony
forming units (CFU). Experiments were performed three times, in
duplicate.
Galleria mellonella killing assay
E. faecalis mutants were grown in GM17 containing 1 mg/ml of
tetracycline and collected by centrifugation 1 h after they had
reached the stationary phase. The VE14089 strain was grown in
GM17. Bacterial cells were washed twice with 0.9% saline solution
and stored as a dry frozen pellet at 280uC. At least two days
before inoculation, the frozen bacterial pellet was suspended in
1 ml of saline solution and serial dilutions were plated on GM17
agar plates in order to determine the bacterial count of the pellet.
Groups of 30 last instar G. mellonella larvae, weighing about
200 mg each, were injected at the base of the last proleg with 10 ml
of a bacterial inoculum (,4610
8 cells per ml) using a
microinjector (KDS 100, KD Scientific Inc.) with a 1-ml syringe
and 0.45- by 12-mm needles (Terumo). A control group of larvae
received 10 ml of a saline solution only. The inoculum size was
confirmed by determining the number of CFU on GM17 agar.
The infected larvae were kept, five per Petri dish, at 37uC and
survival was monitored every 24 h for 2 to 5 days depending on
the experiment. Survival obtained with mutant strains might be
overestimated if gene reversion occurs, although in view of the
short time of the assays, we consider this an unlikely event.
Survival curves were constructed by the Kaplan-Meier method
and compared by log-rank analysis (GraphPad Prism, version 4.0;
GraphPad Software, Inc.). Whereas P values of .0.05 were
considered not significantly different from the VE14089 (nsd), P
values of ,0.05 were considered statistically significant with the
following classification: 0.005,P,0.05 (decreased or increased),
0.0005,P,0.005 (decreased+ or increased+) and P,0.0005
(decreased++ or increased++).
Phenotypic data base construction
Information on the mutant construction (primers and plasmids
used) and on the results of the screening was added in the database
FAECALVIR provided by Migale (INRA, Jouy-en-Josas, France)
and implemented by all the partners of the study (http://genome.
jouy.inra.fr/phenotype/).
Ethics statement
The animal welfare committees of the University of Freiburg
(Regierungspra ¨sidium Freiburg Az 35/9185.81/G-07/15) ap-
proved animal experiments. Rabbit experiments were performed
in compliance with the German animal protection law (TierSchG).
The animals were housed and handled in accordance with good
animal practice as defined by FELASA and the national animal
welfare body GV-SOLAS.
Human PMNs were obtained from healthy volunteers in
accordance with a protocol approved by University of Freiburg
Institutional Review Board for Human Subjects (approval number
116/04). Written informed consent was obtained from all human
volunteers.
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